Cumulative mortality among a simulated general US population and 20 007 individuals diagnosed with cHL at ages 20-74 years and treated with initial chemotherapy. 17 SEER cancer registry areas, 2000-2015 (followed through 2016). (A-C) Cumulative mortality from all causes in the general population and classical Hodgkin lymphoma (cHL) population according to age group. (D-F) Cumulative mortality from lymphomas, noncancers, and other neoplasms among patients diagnosed with stage I/II cHL according to age group. (G-I) Cumulative mortality from lymphomas, noncancers, and other neoplasms among patients diagnosed with stage III/IV cHL according to age group. Shaded areas (and error bars) represent the upper and lower bounds of the 95% CI for cumulative mortality. Reprinted with permission.⁹⁶